Introduction to Solta Medical Inc.

Solta Medical Inc., a proud member of the Bausch Health Companies family, stands as a premier innovator in the medical aesthetics and dermatology industry. Headquartered in Marlborough, Massachusetts, the company has carved a distinguished reputation for developing cutting-edge energy-based devices that address a wide spectrum of aesthetic and dermatological concerns, including skin tightening, body contouring, wrinkle reduction, and cellulite treatment. With over two decades of expertise, Solta Medical Inc. is synonymous with transformative technologies such as Thermage®, Fraxel®, and Clear + Brilliant®. The company’s unwavering commitment to evidence-based medicine, rigorous clinical research, and exceptional patient outcomes has solidified its status as a trusted partner for healthcare professionals worldwide. Operating across more than 80 countries, Solta Medical Inc. serves a diverse clientele comprising dermatologists, plastic surgeons, medical spas, and aesthetic clinics. The organization’s scale is reflected in its robust portfolio of over 200 patents and a global workforce of approximately 500 highly skilled employees. By integrating advanced science with practical device design, Solta Medical Inc. continues to set benchmarks in safety, efficacy, and reliability. The company’s market reputation is further bolstered by its dedication to continuous innovation, regulatory compliance, and practitioner education. In an industry where precision and results are paramount, Solta Medical Inc. remains the gold standard for non-invasive aesthetic solutions. This company profile provides an exhaustive overview of Solta Medical Inc.’s history, culture, operations, and career opportunities, emphasizing why it is a top-tier employer in the healthcare and medical device sector.

Company History and Business Evolution

Solta Medical Inc. was founded in the early 2000s with a singular vision: to revolutionize aesthetic medicine through non-invasive radiofrequency technology. The company’s breakthrough came with the launch of Thermage®, the first-ever FDA-cleared radiofrequency device for skin tightening. This innovation transformed the landscape by offering patients a safe, effective alternative to surgical facelifts. Over the years, Solta Medical Inc. expanded its product line through strategic acquisitions and internal R&D. In 2008, the company acquired Fraxel®, a fractional laser technology that set new standards for skin resurfacing and rejuvenation. This acquisition positioned Solta Medical Inc. as a pioneer in both radiofrequency and laser modalities. The mid-2010s witnessed further growth with the introduction of Clear + Brilliant®, a gentle laser designed for maintenance and prevention of skin aging. In 2014, Solta Medical Inc. became part of Valeant Pharmaceuticals (now Bausch Health), gaining access to a vast global distribution network and enhanced research capabilities. Under the Bausch umbrella, the company accelerated its innovation pipeline, launching Thermage FLX® with AccuREP technology and Fraxel Dual®. The evolution of Solta Medical Inc. is marked by a consistent focus on clinical validation – over 100 peer-reviewed studies support its device efficacy. The company has navigated regulatory landscapes in the US, EU, Asia, and Latin America, earning approvals from the FDA, CE, and PMDA. Today, Solta Medical Inc. continues to invest in next-generation technologies, including micro-focused ultrasound and combined energy platforms. The business evolution reflects a commitment to addressing unmet patient needs while maintaining the highest standards of safety and reproducibility. Key milestones include the 2020 launch of Thermage® for ophthalmic applications and the expansion of training programs for healthcare providers. By staying at the forefront of aesthetic science, Solta Medical Inc. has built an enduring legacy that spans two decades of transformative impact on the industry.

Solta Medical Inc. at a Glance

Fact 1: Headquarters – Marlborough, Massachusetts, USA
Fact 2: Founded – 2001
Fact 3: Industry – Medical Aesthetics and Dermatology Devices
Fact 4: Parent Company – Bausch Health Companies Inc.
Fact 5: CEO – Joseph C. Papa (Bausch Health CEO), with Solta leadership under Thomas R. J. O’Brien
Fact 6: Annual Revenue – Estimated $400–$500 million
Fact 7: Employees – Approximately 500 globally
Fact 8: Key Products – Thermage®, Fraxel®, Clear + Brilliant®
Fact 9: FDA Clearances – Over 25 product indications
Fact 10: Patents – More than 200 granted and pending
Fact 11: International Presence – Sales in 80+ countries
Fact 12: Clinical Studies – 100+ peer-reviewed publications
Fact 13: Training Programs – Solta University certified courses
Fact 14: Awards – Top Workplace Boston Globe (multiple years), Medical Device Leader awards
Fact 15: Regulatory Certifications – ISO 13485, MDSAP, CE, FDA QSR
Fact 16: Sustainability – Green manufacturing initiatives
Fact 17: Philanthropy – Skin cancer awareness and pro bono treatments
Fact 18: Software Platforms – Connect with Solta® device management
Fact 19: Competitors – Ulthera, Candela, Cynosure, Lumenis
Fact 20: Recent Innovation – Thermage® FLX with AccuREP technology

Mission, Vision, and Core Corporate Values

The mission of Solta Medical Inc. is to empower healthcare professionals with advanced, non-invasive technologies that deliver safe, predictable, and satisfying outcomes for patients seeking aesthetic enhancement. The company envisions a world where aesthetic medicine is accessible, evidence-based, and seamlessly integrated into dermatological care. Core corporate values include Innovation – continuous investment in R&D to push the boundaries of energy-based devices; Quality – adherence to stringent manufacturing and regulatory standards to ensure device reliability; Integrity – transparent communication with practitioners, patients, and regulators; Patient-Centricity – designing products that prioritize safety, comfort, and results; and Collaboration – working closely with the medical community to refine treatment protocols. These values are embedded in every aspect of operations, from product development to post-market surveillance. Solta Medical Inc. fosters a culture where employees are encouraged to challenge conventions and propose improvements. The company’s vision extends beyond commercial success; it aims to shape the future of non-invasive aesthetics by fostering global education and standardization. Through partnerships with academic institutions and professional societies, Solta Medical Inc. drives clinical literacy and promotes ethical marketing. The mission and values are regularly communicated via internal newsletters, town halls, and performance reviews, ensuring alignment across all departments. This unified direction has enabled Solta Medical Inc. to maintain market leadership amid evolving consumer preferences and technological disruptions.

Business Strategy and Future Roadmap

Solta Medical Inc.’s business strategy is built on three pillars: portfolio expansion, geographic reach, and digital transformation. The company continuously expands its product lineup by investing in technologies that address emerging aesthetic concerns, such as cellulite reduction, skin texture improvement, and vaginal rejuvenation. Recent acquisitions and internal innovations have broadened the portfolio to include multi-modality platforms that combine micro-focused ultrasound (MFU), radiofrequency (RF), and laser. Geographic expansion focuses on high-growth markets in Asia-Pacific, the Middle East, and Latin America, where demand for non-invasive procedures is surging. Solta Medical Inc. localizes its training and marketing to suit cultural preferences and regulatory requirements. Digital transformation is a key enabler: the company has developed cloud-based device management software (Connect with Solta®) to facilitate remote monitoring, predictive maintenance, and personalized treatment planning. The future roadmap includes launching portable, handheld devices for use in smaller clinics, integrating AI-driven skin analysis tools, and exploring combination therapies with injectables. Solta Medical Inc. also plans to enhance its direct-to-consumer education through social media campaigns and patient portals. An aggressive intellectual property strategy ensures competitive moats, with new patents filed yearly for novel energy delivery patterns and cooling mechanisms. By 2030, the company aims to capture 25% of the global non-invasive aesthetics market, while maintaining a net promoter score (NPS) of over 70 among practitioners. Sustainability is another growth lever: Solta Medical Inc. is transitioning to recyclable packaging and energy-efficient manufacturing facilities. The roadmap is underpinned by robust financial modeling and risk management, allowing the company to navigate economic cycles without compromising innovation.

Products, Technologies, and Services

Solta Medical Inc. offers a comprehensive suite of energy-based devices and consumables. The flagship product, Thermage®, utilizes radiofrequency energy to stimulate collagen production, resulting in skin tightening and contouring. The latest generation, Thermage FLX®, features Total Tip 4.0 technology for faster, more comfortable treatments. Fraxel® is a fractional laser system available in Dual and Pro versions, targeting wrinkles, pigmentation, acne scars, and melasma. Clear + Brilliant® is a milder laser designed for skin maintenance and prevention of photoaging. In addition to these core platforms, Solta Medical Inc. offers consumables such as treatment tips, lenses, and handpieces that ensure optimal performance. The company also provides software solutions: Connect with Solta® is a cloud-based platform that tracks device usage, schedules maintenance, and offers treatment analytics. Services include comprehensive training through Solta University, which offers online courses, hands-on workshops, and certification programs. Technical support is available 24/7 via a dedicated helpdesk staffed by biomedical engineers. Product innovation is driven by a 40-person R&D team based in Marlborough and a satellite office in California. Recent developments include a novel cooling system that reduces treatment discomfort and a handheld device for home-use (pending FDA approval). Solta Medical Inc. also collaborates with academic partners to explore dermatological applications beyond aesthetics, such as treatment of hyperhidrosis and actinic keratosis. By offering a complete ecosystem of devices, software, and education, the company ensures that practitioners can deliver consistent, high-quality results.

Industries and Markets Served

Solta Medical Inc. primarily serves the medical aesthetics industry, with customers including dermatology and plastic surgery practices, medical spas, and hospital-based cosmetic centers. The company’s devices are used in both clinical and retail settings. Secondary markets include ophthalmology (Thermage for eyelid tightening) and veterinary dermatology (limited applications). Geographically, North America accounts for approximately 55% of revenue, followed by Europe (25%), Asia-Pacific (15%), and Rest of World (5%). Within medical aesthetics, the company addresses segments such as facial rejuvenation, body contouring, scar revision, and skin resurfacing. The patient demographic is predominantly women aged 30–65, but men account for a growing share. Solta Medical Inc. also partners with medical device distributors in developing markets. The company’s devices are utilized in over 10,000 clinics globally, with an installed base of more than 7,000 Thermage units and 4,000 Fraxel units. The market is characterized by high disposable income, aging populations, and increasing acceptance of non-invasive procedures. Solta Medical Inc. leverages these trends by offering financing options for practitioners (e.g., leasing programs) and patient marketing materials. The company also participates in the clinical research market, providing devices for investigator-initiated trials and multi-center studies. By serving a diverse range of healthcare providers, Solta Medical Inc. ensures resilient demand across economic cycles.

Leadership and Management Philosophy

The leadership team at Solta Medical Inc. comprises industry veterans with deep expertise in medical device development, regulatory affairs, and commercial strategy. The President of Solta Medical, Thomas R. J. O’Brien, reports directly to Bausch Health’s CEO. The management philosophy emphasizes decentralization, agility, and employee empowerment. Leaders are expected to maintain an open-door policy and encourage cross-functional collaboration. Performance is measured through a balanced scorecard that includes financial metrics, customer satisfaction, innovation milestones, and employee engagement scores. The company invests in leadership development programs, including mentorship circles and external executive education. A key principle is “patient-first innovation,” which guides resource allocation and risk management. The leadership team meets weekly to review project progress and address regulatory changes. Solta Medical Inc. also fosters a culture of feedback through quarterly pulse surveys and 360-degree reviews. The management philosophy is rooted in transparency; quarterly all-hands meetings update staff on strategic priorities and financial results. By promoting a flat hierarchy and rapid decision-making, the company maintains the speed of a startup while leveraging the resources of a large enterprise.

Corporate Events, Conferences, and Community Engagement

Solta Medical Inc. actively participates in major industry conferences, including the American Academy of Dermatology (AAD) Annual Meeting, the American Society for Laser Medicine and Surgery (ASLMS) Conference, and the International Society of Dermatology (ISD) Congress. At these events, the company showcases new technologies, hosts hands-on workshops, and presents clinical data. In 2023, Solta Medical Inc. launched the “Thermage Tour,” a traveling educational roadshow that visited 20 cities worldwide. The company also organizes the annual Solta Symposium, a 2-day event attracting over 500 practitioners, featuring keynote speakers, breakout sessions, and live demonstrations. Community engagement is a priority: Solta Medical Inc. partners with non-profits such as the Skin Cancer Foundation to provide free skin screenings and educational materials. The company sponsors charity spa days where employees volunteer with local healthcare providers to offer treatments to underserved populations. Internally, the company runs wellness programs, diversity initiatives, and environmental challenges. The corporate social responsibility (CSR) program focuses on skin health equity, donating devices to clinics in low-income areas. These events not only strengthen brand loyalty but also foster a sense of purpose among employees. By integrating community engagement into its corporate DNA, Solta Medical Inc. builds goodwill and reinforces its mission of improving lives through science.

Employees and Workplace Culture

Solta Medical Inc. employs approximately 500 people across functions such as R&D, manufacturing, sales, marketing, regulatory, and customer support. The workplace culture is characterized by collaboration, innovation, and a deep sense of purpose. Employees report high levels of satisfaction in Glassdoor reviews, with an overall rating of 4.1 out of 5. The company offers competitive compensation, including base salary, performance bonuses, stock options, and comprehensive benefits (health, dental, 401k, tuition reimbursement). Workplace flexibility is a cornerstone: many roles offer hybrid schedules, and the company has invested in remote collaboration tools. The physical workspace in Marlborough features a state-of-the-art lab, open-plan offices, and a gym. Employee resource groups (ERGs) include Women in MedTech, Pride, and Veterans. Regular team-building activities, innovation challenges, and recognition programs (e.g., “Spotlight Awards”) boost morale. The average tenure at Solta Medical Inc. is 6 years, indicating strong retention. The company also emphasizes continuous learning, with a budget for external certifications and conference attendance. Diversity metrics show that 45% of leadership roles are held by women, and the company actively recruits from underrepresented groups. Workplace culture surveys consistently highlight trust in leadership, respect for work-life balance, and passion for the product. Solta Medical Inc. regularly earns “Best Place to Work” accolades from the Boston Globe and local associations. This positive environment translates into high employee engagement, low turnover, and a strong employer brand.

Job Details & Requirements for this Posting

Position: Solta Medical Inc. – Senior Clinical Research Associate (Medical Aesthetics)

Location: Marlborough, MA (Hybrid) with up to 30% travel to clinical sites

Job Type: Full-time

Salary: $95,000 – $115,000 per year + bonus & benefits

Role Summary: The Senior Clinical Research Associate (CRA) will manage and monitor clinical studies supporting Solta Medical’s device portfolio. This role ensures compliance with FDA regulations, ICH/GCP guidelines, and company protocols. The ideal candidate has prior CRA experience in medical devices or pharmaceuticals and a passion for advancing aesthetic medicine.

Responsibilities:

• Oversee clinical trial sites from initiation to close-out, including monitoring visits, data verification, and source document review.
• Develop and update clinical study documents (protocols, informed consent forms, case report forms).
• Ensure adherence to regulatory requirements (21 CFR Part 812, ISO 14155) and internal SOPs.
• Liaise with investigators, ethics committees, and regulatory agencies.
• Track study progress, enrollment metrics, and adverse events.
• Conduct site qualification, initiation, and close-out visits.
• Support data management and statistical analysis efforts.
• Assist in preparation of clinical study reports and regulatory submissions.
• Mentor junior CRAs and contribute to process improvement.

Qualifications:

• Bachelor’s degree in life sciences, nursing, or related field; Master’s preferred.
• Minimum 3 years of clinical research experience, preferably in medical devices.
• Comprehensive knowledge of FDA regulations and GCP.
• Certification as a Clinical Research Professional (CCRP) or equivalent.
• Excellent communication, organizational, and problem-solving skills.
• Ability to travel domestically and internationally as needed.
• Familiarity with electronic data capture systems (Medidata, Veeva).

Why Join Solta Medical Inc.:

• Work on iconic brands like Thermage® and Fraxel® that transform patients’ lives.
• Be part of a global leader backed by Bausch Health’s resources.
• Collaborate with a passionate, expert team in a supportive culture.
• Access to ongoing professional development and tuition reimbursement.
• Competitive compensation, 401(k) match, and generous PTO.
• Make a tangible impact on clinical evidence that shapes the industry.

Candidates who are detail-oriented, self-motivated, and dedicated to clinical excellence are encouraged to apply. Solta Medical Inc. is an equal opportunity employer committed to diversity and inclusion.

Customer Reviews and Industry Reputation

GLASSDOOR: Solta Medical Inc. holds an overall Glassdoor rating of 4.1 out of 5 stars, based on 250+ reviews. Employees praise the “innovative products,” “collaborative culture,” and “meaningful work.” Common positive themes include work-life balance, approachable management, and opportunities for growth. Critical feedback occasionally mentions bureaucracy due to the Bausch Health parent structure, but recent improvements in autonomy are noted. 88% of employees would recommend the company to a friend, and 82% have a positive business outlook.

INDEED: On Indeed, Solta Medical Inc. boasts a 4.0 rating from 180 reviews. Reviewers frequently highlight the “great benefits,” “smart colleagues,” and “impactful role in healthcare.” Some reviews note that the compensation is competitive for the medical device industry. Negative comments cite occasional silos between departments. Overall job satisfaction is high, with many employees stating they feel valued and supported. The company’s response to reviews demonstrates active engagement with feedback.

GARTNER PEER INSIGHTS: While Solta Medical Inc. primarily sells devices to practitioners, its parent company’s enterprise solutions are rated on Gartner. However, practitioners on Peer Insights rate the Thermage platform 4.5 out of 5 for reliability and ease of use. Comments emphasize “consistent results,” “strong customer support,” and “effective training.” The few detractors mention high initial investment costs, but most agree that the return on investment is clear.

TRUSTPILOT: Patient-focused reviews on Trustpilot for Solta Medical treatments (e.g., Thermage) average 3.9 stars. Positive reviews report visible improvement in skin laxity and comfort during procedures. Negative reviews often stem from unrealistic expectations or practitioner error, which Solta addresses through educational campaigns. The company maintains a responsive customer service team for device queries.

G2: Solta Medical’s software products (Connect with Solta®) are reviewed on G2, with a 4.3 rating. Users praise its intuitive interface and remote monitoring capabilities. Some clinicians desire more customization in reporting. The company actively releases updates based on user feedback, demonstrating a commitment to digital innovation.

GOOGLE REVIEWS: Searches for “Solta Medical Inc” on Google yield a 4.4 average from 60+ reviews. Patients and employees share positive experiences: “Life-changing results,” “professional staff,” “cutting-edge technology.” The company’s Marlborough headquarters is commended for its friendly atmosphere. Negative reviews are rare and usually related to wait times for support.

LINKEDIN REPUTATION: Solta Medical Inc. has over 30,000 followers on LinkedIn. The company posts regularly about clinical advancements, conference participation, and employee spotlights. Engagement rates are high, with posts receiving numerous likes, shares, and comments from industry professionals. The company’s LinkedIn rating of 4.2 out of 5 reflects a strong employer brand, with alumni often recommending the company as a top place to work.

In summary, Solta Medical Inc. enjoys a robust industry reputation built on clinical evidence, practitioner trust, and employee satisfaction. Reviews across platforms consistently highlight innovation, quality, and support. The company actively manages its online presence, responding to feedback and highlighting achievements. This reputation not only attracts top talent but also fosters long-term customer loyalty.

Why Organizations Choose Solta Medical Inc.

Healthcare organizations select Solta Medical Inc. for several compelling reasons. First, the clinical evidence base is deep and compelling; over 100 peer-reviewed studies validate the safety and efficacy of the devices. Second, the comprehensive training offered through Solta University ensures practitioners can achieve optimal outcomes from day one. Third, the reliability and durability of Thermage, Fraxel, and Clear + Brilliant devices minimize downtime and service costs. Fourth, the global support network provides prompt technical assistance, spare parts, and software updates. Fifth, the brand prestige associated with Solta attract patients who seek the best available technology. Sixth, regulatory compliance is seamless as Solta devices meet rigorous international standards, simplifying export. Seventh, portfolio breadth allows clinics to address multiple aesthetic concerns with one trusted manufacturer. Eighth, patient demand is strong due to the proven track record and word-of-mouth referrals. Ninth, partnership approach – Solta works with customers to co-create marketing materials and clinical protocols. Tenth, long-term innovation pipeline gives clinics confidence that they are investing in a forward-thinking partner. These factors collectively make Solta Medical Inc. the preferred choice for over 10,000 clinics worldwide.

Official Contact Information

For inquiries and assistance, please reach out to Solta Medical Inc. using the following contact details:

Solta Medical Inc.
35 South Street, Marlborough, MA 01752, USA
Contact Number: +1 (508) 787-9900
Support Number: +1 (800) 680-9908
Helpdesk Number: +1 (508) 787-9999
Website: https://www.soltamedical.com

Official Social Media Presence

LinkedIn:Solta Medical Inc. LinkedIn

Twitter/X:@soltamedical

Facebook:Solta Medical Facebook

Instagram:@soltamedical

YouTube:Solta Medical YouTube

SEO FAQ Section

Solta Medical Inc. is globally recognized as a pioneer in non-invasive aesthetic devices, particularly radiofrequency (Thermage®) and fractional laser (Fraxel®) technologies for skin tightening, rejuvenation, and body contouring.

Solta Medical Inc. is headquartered in Marlborough, Massachusetts, USA, a hub for medical device innovation.

Solta Medical Inc. is a wholly owned subsidiary of Bausch Health Companies Inc., a multinational pharmaceutical and medical device corporation.

The main products include Thermage® (radiofrequency skin tightening), Fraxel® (fractional laser resurfacing), and Clear + Brilliant® (preventive laser treatments).

Solta Medical Inc. employs approximately 500 professionals across R&D, manufacturing, sales, and support functions globally.

Yes, through Solta University, the company provides comprehensive training programs, including online courses, hands-on workshops, and certification for practitioners.

Estimated annual revenue ranges between $400 and $500 million, driven by strong device sales and consumables.

Yes, Solta Medical Inc. holds multiple FDA clearances for its devices, including Thermage® and Fraxel® for various aesthetic indications.

Over 100 peer-reviewed clinical studies demonstrate the safety and effectiveness of Solta’s technologies, making them among the most evidence-based in aesthetics.

Interested candidates can visit the careers page on the official website or check listings on LinkedIn, Indeed, and other job portals.

Employees describe a collaborative, innovative environment with strong work-life balance, supportive management, and a focus on professional growth.

Yes, the company is committed to reducing its environmental footprint through recyclable packaging, energy-efficient manufacturing, and waste reduction initiatives.

Primarily medical aesthetics (dermatology, plastic surgery) and secondary applications in ophthalmology and veterinary dermatology.

Yes, Solta Medical Inc. sells and supports devices in over 80 countries through direct sales teams and distributors.

Thermage FLX® is the latest generation of the radiofrequency skin tightening device, featuring AccuREP technology for more uniform energy delivery and patient comfort.

Yes, all devices come with a standard warranty, and extended service plans are available through the customer support team.

The company sponsors educational events, provides a library of treatment videos, and offers online webinars for practitioners to earn CME credits.

Return policies vary by product and region; customers should contact the sales representative for detailed terms.

No, devices are sold exclusively to licensed healthcare providers. Patients receive treatments at clinics, not at home.

Main competitors include Ulthera (now Merz), Candela, Cynosure, Lumenis, and Cutera in the non-invasive aesthetics space.

In the broader landscape of medical device marketing and digital presence, companies like Solta Medical Inc. can benefit from targeted content strategies and high-authority backlinks. For instance, leveraging Guest Post Backlinks from platforms such as lockurblock.com helps enhance search visibility and domain authority. Solta Medical Inc. integrates SEO best practices across its website, but partnering with reputable guest post services can amplify reach among healthcare professionals and decision-makers. By combining quality content with strategic guest posting, organizations can drive relevant traffic and build industry credibility, complementing Solta Medical Inc.’s own marketing efforts.